跳至主要内容
临床试验/NCT02409550
NCT02409550已完成不适用

CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children

Stefania La Grutta, MD1 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
113
试验地点
1
主要终点
CARATKids Italian language validation

研究概览

简要总结

This project is an observational study for the Italian language validation of the CARATKids questionnaire investigating the asthma and coexisting allergic rhinitis control in children. 113 patients with concomitant asthma and allergic rhinitis followed up from at least 3 months will be enrolled for the validation process at outpatient clinic of Pediatric Allergology & Pulmonology (PAP) of Respiratory Disease Research Center (RDRC) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR), Italy.

The study will be completed in two medical examination, within 3-6 weeks of each other.

CARATKids questionnaire, VAS (Visual Analogic Scale) and C-ACT (Children Asthma Control Test) will be filled by each patient.

The main outcome is the Italian language validation of the CARATKids questionnaire investigating the coexisting asthma and allergic rhinitis control in children.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
6 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 113 patients with concomitant asthma and allergic rhinitis followed up from at least 3 months
  • 12 < years old > 6

排除标准

  • Patients with asthma only or allergic rhinitis only, or younger or older than the targeted age group

结局指标

主要结局

CARATKids Italian language validation

时间窗: 3 weeks

The main objective of the study is the assessment process of the tool CARATKids, in a scholastic children Italian population affected by coexisting asthma and allergic rhinitis.

次要结局

未报告次要终点

研究者

发起方
Stefania La Grutta, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stefania La Grutta, MD

Stefania La Grutta, MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.

Istituto per la Ricerca e l'Innovazione Biomedica

研究点 (1)

Loading locations...

相似试验